Masking / Blinding

Trial,study,clinical trials,treatment,outcome,analysis,allocation,care,active treatment,treatment assignments,randomized trial,randomised trials,outcome assessors,subjective outcomes,masking,allocation concealment,authors,

Effects,care providers,access,random assignment,medical treatment,primary outcome,outcome assessments,pain relief,Clin Trials,Bias,Moher D,therapy,Selection bias,Grimes DA,Ghali WA,ascertainment bias,standard treatment.

Treatment arms,actual treatment assignment,assigned treatment,knowledge about treatment assignment,placebo treatments,outcome measure,study participants,pain,controls in medicine,definitions of masking,bias in assessment,bias in assignment,benefit,Bang,efficacy,Moher D. Blinding.

Electronic access,Morris D,,Morris et al,cardiovascular disease,quality,quality of life,Chalmers I,sources of bias,Attrition bias,performance bias,Bull Hist Med,Gebski VJ,Keech AC,major advantage,Manns BJ,manuscript writers,poor vision,placebo controls,blind assessment,Fraser S,preferred treatment,pharmacologic treatments,double-blind trial,double-blind, randomized clinical trial,pharmacological trials,placebo-controlled drug trial,Pragmatic trials,incomplete outcome,positive outcome,study protocol,study group assignment,clinical study,methodological study,original study population,primary analysis,protocol analysis,subset analysis,approaches to analysis,cardiac pain,pain in patients,pain scale,Internal Medicine,Journal of General Internal Medicine,Population Medicine,real world medicine,Wormald R. Masking,Fraser S. Masking,allocation schedule,concealment of allocation,Contemp Clin Trials,Clin Pharmacol Ther,Control Clin Trials,bias in endpoint assessment,benefit in humans,potential benefit,realistic benefit,survey of authors,author reply,Bang BI,Bang H,efficacy of glucosamine,lack of efficacy,”Moher D.,”,expansion therapy,light therapy,moderate effects,posttreatment effects,method of care,normal access,Morris,arterial disease,coronary disease,Healthcare Research and Quality.